Author:
Zhang Li,Li Su,Zhang Yang,Zhan Jing,Zou Ben-Yan,Smith Robert,Martin Paul D.,Jiang Yinrui,Liao Hai,Guan Zhongzhen
Subject
Pharmacology (medical),Pharmacology
Reference29 articles.
1. Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors;Hennequin;J Med Chem,2002
2. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration;Wedge;Cancer Res,2002
3. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase;Ciardiello;Clin Cancer Res,2003
4. ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases;Carlomagno;Cancer Res,2002
5. Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells;Vitagliano;Cancer Res,2004
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献